BOEHRINGER INGELHEIM is pleased to invite you to participate in this live webinar with international and Australian respiratory experts, to explore the role of inhalers in patient outcomes, identify relevant patient factors and inhaler characteristics, and discuss best practice for optimising patients’ use of their inhalers.
You will have the opportunity to have your questions answered by the experts in a live and interactive Q&A session, moderated by Dr Brad McKay.
REGISTER NOW for your preferred webinar date
Dr Scott Claxton &
7:00 pm AWST
9:00 pm AEST (QLD)
9:30 pm ACDT (SA)
10:00 pm AEDT (NSW/VIC/TAS)
Dr Omar Usmani &
Prof Sinthia Bosnic-Anticevich
7:30 pm AEDT
4:30 pm AWST (WA)
6:30 pm AEST (QLD)
7:00 pm ACDT (SA)
A selection of patient resources will be available in the portal once you have accessed the webinar.
Meet the experts
Dr Brad McKay
General Practitioner, TV presenter, author, and columnist
Dr Omar Usmani
MBBS, PhD, FHEA, FRCP, FERS
Reader in Respiratory Medicine & Consultant Respiratory Physician at Imperial College London
Prof Sinthia Bosnic-Anticevich
Respiratory Researcher & Pharmacist, Woolcock Institute of Medical Research, Sydney
Prof David Price
Primary Care Respiratory Society Professor of Primary Care Respiratory Medicine at the University of Aberdeen, UK; Managing Director of Observational and Pragmatic Research Institute, Singapore
A/Prof Debbie Rigby
Consultant clinical pharmacist; Adjunct Associate Professor, School of Pharmacy, University of Queensland; Associate Clinical Professor, School of Clinical Sciences, QUT
Dr Scott Claxton
Respiratory and Sleep Physician, GenesisCare WA
General Practice Pharmacist, Perth WA
Dr Brad McKay MBBS
Dr Brad McKay is a General Practitioner who currently works in Darlinghurst, Sydney. He was accepted into medicine when he was only 16 years old and was working as a doctor by the age of 21. As a medical practitioner he has worked with Aboriginal communities in regional Australia, as an Emergency Registrar in Ireland, and as a GP in Melbourne and Sydney. He provides health care for the homeless and is also a HIV Clinician.
Professor David Price FRCGP
Prof David Price is head of The Observational & Pragmatic Research Institute (Singapore) and Optimum Patient Care (Australia and UK), and is Primary Care Respiratory Society Professor of Primary Care Respiratory Medicine at the University of Aberdeen (UK). His area of interest lies in real life respiratory and allergy research. To date he has authored over 490 peer-reviewed publications and is responsible for approximately US$50 million in research and clinical development grants. In addition, he established the Optimum Patient Care Research Database (OPCRD; http://opcrd.co.uk/) with over 8 million patients, and the first International Severe Asthma Registry (ISAR; http://isaregistries.org/) with over 30 countries collaborating. He is currently Editor-in-Chief of Pragmatic and Observational Research and member of the editorial board of several respiratory journals, including The Lancet Respiratory Medicine.
Dr Omar Usmani MBBS, PhD, FHEA, FRCP
Dr Omar Usmani is Reader in Respiratory Medicine and Consultant Physician at the National Heart and Lung Institute (NHLI), Imperial College London & Royal Brompton Hospital (RBH). He is an International Authority on Aerosol Science and Inhalation Medicine whose research has fundamentally changed the understanding of therapeutic aerosol deposition and clinical effectiveness in inhaled drug delivery to the lungs. In 2015, he was awarded one of the highest accolades in Aerosol Science, the Thomas T Mercer Award from the American Association of Aerosol Research (AAAR) and the International Society of Aerosols in Medicine (ISAM), recognising his International Research Excellence in Pharmaceutical Aerosols and Inhalable Materials.
His Research Themes are Inhaled Drug Delivery, Small Airways Physiology, Lung Imaging, Respiratory Pharmacology and Tele-monitoring / E-health. He has pioneered novel and sophisticated techniques of assessing inhaled drug delivery, detecting dysfunction of small airways physiology, and characterising airflow heterogeneity using pulmonary imaging, in order to understand structure-function-treatment relationships within the lungs.
Associate Professor Debbie Rigby
A/Prof Debbie Rigby is an Advanced Practice Pharmacist with postgraduate qualifications in clinical pharmacy, geriatrics and respiratory medicine. A/Prof Rigby is a past Director of NPS MedicineWise and National Vice-President of the Pharmaceutical Society of Australia. She currently conducts Home Medicine Reviews and provides medicines education to pharmacists, nurses, GPs and other health professionals through her company Pharmeducation. For her passion and commitment to the pharmacy profession and quality use of medicines, Debbie has received numerous awards including PSA Pharmacist of the Year, the inaugural AACP Consultant Pharmacist of the Year, SHPA Clinical Pharmacy Award and the 2020 PSA Lifetime Achievement Award.
Prof Sinthia Bosnic-Anticevich is an internationally recognised expert in the area of inhaler use and quality use of respiratory medicines. Originally trained as a pharmacist and basic scientist, she spent several years working in the pharmaceutical industry before returning to the Faculty of Pharmacy, University of Sydney as a full-time academic. In 2013, Prof Bosnic-Anticevich joined the Woolcock Institute of Medical Research as founder and Team Leader of the Quality Use of Respiratory Medicines Group. The group focuses on understanding the factors contributing to suboptimal use of respiratory medicines and developing novel and effective strategies to overcoming barriers to inappropriate use, which practising health care providers can use in day to day practice. She is currently Chair of ARIA in Pharmacy, President of the Respiratory Effectiveness Group and serves on the board of several high impact respiratory journals and advisory boards.
Dr Scott Claxton FRACP
Dr Scott Claxton is a Sleep and Respiratory Physician with GenesisCare based at Joondalup but consulting throughout the Perth metro area. He practices in all areas of sleep and respiratory medicine with particular interests in airways disease and respiratory failure.
Mayli Foong is an experienced General Practice Pharmacist. She commenced with PSA and WAPHA to deliver Western Australia’s first non-dispensing Pharmacist in General Practice program in 2018. Since its inception she has mentored other GP Pharmacists and delivered education and innovation to this program. Her interests lie in improving transitions of care between tertiary and primary health care, and chronic disease management. She has a particular interest in COPD and asthma. She currently works collaboratively within General practice to screen at risk patients and support practice staff to provide early intervention by aligning the latest treatment guidelines through a multidisciplinary approach to chronic disease management.
She is an accomplished accredited pharmacist conducting Home Medication Reviews and Residential Medication Management Reviews for over 18 years. Her previous experience includes working in both hospital and community settings and as chief pharmacist at Joondalup Health Campus. She has provided advice to various committees including Drug in Therapeutics and WAPHA’s Health Pathways as well as delivering expert education on respiratory disease to GPs and other allied health professionals.